GCEIP 500 Global rank #47 · United States
Abbott: diagnostics, devices and nutrition in everyday healthcare
Abbott sells products used in clinics, hospitals and homes, from diagnostic tests and medical devices to nutrition products and medicines. Its FY2025 results show that international markets account for a large part of its sales.
The company
What it does
Abbott Laboratories develops and sells medical devices, diagnostic products, nutrition products and established pharmaceuticals. The company serves consumers and healthcare providers in the United States and international markets.
Across markets
Abbott reported $44.3 billion in sales for 2025, including $27.2 billion in international sales. Medical devices were its largest segment by reported sales, with diagnostics, nutrition and pharmaceuticals also contributing. These figures show where the business operates; they do not measure patient outcomes. Abbott’s products can affect diagnosis, chronic-disease management and nutrition, so accessibility, safety and clinical evidence are central to their public value.
The company’s footprint and context are linked to the public sources below.
GCEIP view
What the record tells us
TIME named Abbott to its 2025 TIME100 Companies list, an editorial selection rather than an award. GCEIP sees the company’s case in the breadth of products used across healthcare settings and consumer markets. Its scale gives it significant reach, while the impact of that reach depends on product performance, access and the evidence supporting each medical use.
Published recognition
Selected results
See published awards and company-list results 1 sources
- TIME100 Most Influential Companies · 2025View source
TIME100 Companies selection
Named by TIME editors among 105 businesses for company-specific influence, impact, innovation, ambition or success; analysis of the specific business case pending